<DOC>
	<DOCNO>NCT02518971</DOCNO>
	<brief_summary>The study aim evaluate efficacy prophylactic tamsulosin reduce incidence postoperative urinary retention primary total knee hip arthroplasty patient .</brief_summary>
	<brief_title>Trial Prophylactic Tamsulosin Postoperative Urinary Retention Primary Total Hip Knee Arthroplasty Patients</brief_title>
	<detailed_description>Prophylactic administration tamsulosin compare placebo evaluate effectiveness reduce incidence postoperative urinary retention total hip knee arthroplasty patient .</detailed_description>
	<mesh_term>Urinary Retention</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Men age 35 old Primary total hip knee arthroplasty patient ( general , spinal , epidural anesthesia No current use ( &gt; 1 month ) alphablockers Community ambulator Adequate organ marrow function define : leucocyte least 3,000/µL , absolute neutrophil count least 1,500/µL , platelet least 100,000/µL , creatinine within normal institutional limit Ability understand , willingness sign , write informed consent History radical prostatectomy Receiving investigational agent Revision hip knee arthroplasty patient Severe liver kidney disease Taking strong inhibitor CYP3A4 ( ketoconazole , itraconazole , clarithromycin , ritonavir , indinavir/ritonavir , lopinavir , conivaptan ) Being alphablockers ( alfuzosin , doxazosin , prazosin , terazosin , tamsulosin , phenoxybenzamine , silodosin ) Being 5alpha reductase inhibitor ( finasteride , dutasteride ) History allergy sensitivity tamsulosin alphablockers ( alfuzosin , doxazosin , prazosin , terazosin , phenoxybenzamine ) Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement Taking Sildenafil , Tadalafil , Vardenafil</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>